Skip to main content
Log in

Immunocryosurgery for basal cell carcinoma: impact on circulating CD4+ CD25high T regulatory cells and serum cytokines

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kaporis HG, Guttman-Yassky E, Lowes M, et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007; 127: 2391–8.

    Article  CAS  Google Scholar 

  2. Gaitanis G, Bassukas ID. Immunocryosurgery for non-superficial basal cell carcinoma: a prospective, open-label phase III study for tumours ≤2 cm in diameter. Acta Derm Venereol 2014; 94: 38–44.

    Article  Google Scholar 

  3. Gaitanis G, Alexopoulos EC, Bassukas ID. Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label study. Eur J Dermatol 2011; 21: 952–8.

    Article  Google Scholar 

  4. Nomikos K, Lampri E, Spyridonos P, Bassukas ID. Alterations in the inflammatory cells infiltrating basal cell carcinomas during immunocryosurgery. Arch Dermatol Res 2019; 311: 499–504.

    Article  CAS  Google Scholar 

  5. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016; 16: 626–38.

    Article  CAS  Google Scholar 

  6. Gaitanis G, Bassukas ID. Intralesional bevacizumab as in-add adjuvant to immunocryosurgery for locally advanced basal cell carcinoma. J Eur Acad Dermatol Venereol 2014; 28: 1117–21.

    Article  CAS  Google Scholar 

  7. Bassukas ID, Gaitanis G. Combination of cryosurgery and topical imiquimod: does timing matter for successful immunocryosurgery? Cryobiology 2009; 59: 116–7.

    Article  Google Scholar 

  8. Skov L, Allen MH, Bang B, et al. Basal cell carcinoma is associated with high TNF-alpha release but nor with TNF-alpha polymorphism at position-308. Exp Dermatol 2003; 12: 772–6.

    Article  CAS  Google Scholar 

  9. Sobjanek M, Zabłotna M, Bień E, et al. Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma. Biomark Med 2016; 10: 185–95.

    Article  CAS  Google Scholar 

  10. Bassukas ID, Ganiatsa A, Gaitanis G. Health-related quality of life associated with immunocryosurgery, a minimally invasive modality, for cervicofacial basal cell carcinoma. Eur J Dermatol 2019; 29: 234–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ioannis D. Bassukas.

Additional information

Disclosure

Funding sources: this study was partially supported by the University of Ioannina; Research Committee Account 22195. Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaitanis, G., Ganiatsa, A., Vartholomatos, G. et al. Immunocryosurgery for basal cell carcinoma: impact on circulating CD4+ CD25high T regulatory cells and serum cytokines. Eur J Dermatol 30, 605–606 (2020). https://doi.org/10.1684/ejd.2020.3864

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2020.3864

Navigation